From Medical News Today, word on a – possibly – promising treatment for those who have Parkinson’s Disease.
Scientists have known for some time that there are links between the decline of cells that produce dopamine – a key neurotransmitter – and loss of motor function in Parkinson’s patients.
They found that the molecule — BT13 — was indeed able to boost dopamine in the brains of mice. It also appeared to protect the brain cells tasked with dopamine production from dying off and, unlike [GDNF, a treatment that required invasive surgery], it was able to bypass the blood-brain barrier.
The study is still in the very early stages, but it could lead to a pharmaceutical treatment for the motor function loss associated with the disease. It’s still early, but this is a study to keep an eye on going forward.
Brought to you by smpltec.com, Technology for Seniors News.